Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 96HORIZON

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CYSTEAMINE BITARTRATE

US Patent Number : 9198882

Drug Substance Claim :

Drug Product Claim :

Application Number : 203389

Patent Use Code : U-1399

Delist Requested :

Patent Use Description : MANAGEMENT OF NEPHROPA...

Patent Expiration Date : 2027-01-26

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CYSTEAMINE BITARTRATE

US Patent Number : 9192590

Drug Substance Claim :

Drug Product Claim :

Application Number : 203389

Patent Use Code : U-1399

Delist Requested :

Patent Use Description : MANAGEMENT OF NEPHROPA...

Patent Expiration Date : 2027-01-26

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CYSTEAMINE BITARTRATE

US Patent Number : 8026284

Drug Substance Claim :

Drug Product Claim :

Application Number : 203389

Patent Use Code : U-1399

Delist Requested :

Patent Use Description : MANAGEMENT OF NEPHROPA...

Patent Expiration Date : 2027-09-22

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CYSTEAMINE BITARTRATE

US Patent Number : 8026284

Drug Substance Claim :

Drug Product Claim :

Application Number : 203389

Patent Use Code : U-1399

Delist Requested :

Patent Use Description : MANAGEMENT OF NEPHROPA...

Patent Expiration Date : 2027-09-22

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CYSTEAMINE BITARTRATE

US Patent Number : 9192590

Drug Substance Claim :

Drug Product Claim :

Application Number : 203389

Patent Use Code : U-1399

Delist Requested :

Patent Use Description : MANAGEMENT OF NEPHROPA...

Patent Expiration Date : 2027-01-26

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CYSTEAMINE BITARTRATE

US Patent Number : 9198882

Drug Substance Claim :

Drug Product Claim :

Application Number : 203389

Patent Use Code : U-1399

Delist Requested :

Patent Use Description : MANAGEMENT OF NEPHROPA...

Patent Expiration Date : 2027-01-26

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CYSTEAMINE BITARTRATE

US Patent Number : 9925158

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203389

Patent Use Code : U-1399

Delist Requested :

Patent Use Description : MANAGEMENT OF NEPHROPA...

Patent Expiration Date : 2027-01-26

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CYSTEAMINE BITARTRATE

US Patent Number : 9925157

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203389

Patent Use Code : U-1399

Delist Requested :

Patent Use Description : MANAGEMENT OF NEPHROPA...

Patent Expiration Date : 2027-01-26

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CYSTEAMINE BITARTRATE

US Patent Number : 9925158

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203389

Patent Use Code : U-1399

Delist Requested :

Patent Use Description : MANAGEMENT OF NEPHROPA...

Patent Expiration Date : 2027-01-26

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CYSTEAMINE BITARTRATE

US Patent Number : 10143665

Drug Substance Claim :

Drug Product Claim :

Application Number : 203389

Patent Use Code : U-1399

Delist Requested :

Patent Use Description : MANAGEMENT OF NEPHROPA...

Patent Expiration Date : 2036-08-16

blank